These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 10933655

  • 21. Antimicrobial Susceptibility of Francisella tularensis Isolates in the United States, 2009-2018.
    Choat J, Young J, Petersen JM, Dietrich EA.
    Clin Infect Dis; 2024 Jan 31; 78(Suppl 1):S4-S6. PubMed ID: 38294116
    [Abstract] [Full Text] [Related]

  • 22. [Sensitivity spectrum of Francisella tularensis to antibiotics and synthetic antibacterial drugs].
    Vasi'lev NT, Oborin VA, Vasi'lev PG, Glushkova OV, Kravets ID, Levchuk BA.
    Antibiot Khimioter; 1989 Sep 31; 34(9):662-5. PubMed ID: 2610533
    [Abstract] [Full Text] [Related]

  • 23. A new dye uptake assay to test the activity of antibiotics against intracellular Francisella tularensis.
    Sutera V, Caspar Y, Boisset S, Maurin M.
    Front Cell Infect Microbiol; 2014 Sep 31; 4():36. PubMed ID: 24672776
    [Abstract] [Full Text] [Related]

  • 24. Septic pneumonic tularaemia caused by Francisella tularensis subsp. holarctica biovar II.
    Fritzsch J, Splettstoesser WD.
    J Med Microbiol; 2010 Sep 31; 59(Pt 9):1123-1125. PubMed ID: 20522628
    [Abstract] [Full Text] [Related]

  • 25. New therapeutic approaches for treatment of tularaemia: a review.
    Boisset S, Caspar Y, Sutera V, Maurin M.
    Front Cell Infect Microbiol; 2014 Sep 31; 4():40. PubMed ID: 24734221
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Ciprofloxacin for treatment of tularemia in children.
    Johansson A, Berglund L, Gothefors L, Sjöstedt A, Tärnvik A.
    Pediatr Infect Dis J; 2000 May 31; 19(5):449-53. PubMed ID: 10819342
    [Abstract] [Full Text] [Related]

  • 30. [Sensitivity of the causative agent of tularemia to antibiotics].
    Kudelina RI.
    Antibiotiki; 1978 Aug 31; 23(8):710-4. PubMed ID: 686695
    [Abstract] [Full Text] [Related]

  • 31. Susceptibility of 71 French isolates of Francisella tularensis subsp. holarctica to eight antibiotics and accuracy of the Etest method.
    Valade E, Vaissaire J, Mérens A, Hernandez E, Gros C, Le Doujet C, Paucod JC, Thibault FM, Durand B, Lapalus M, Dupuis I, Caclard A, Vidal DR, Cavallo JD.
    J Antimicrob Chemother; 2008 Jul 31; 62(1):208-10. PubMed ID: 18397924
    [No Abstract] [Full Text] [Related]

  • 32. Discovery of D8-03 as an Inhibitor of Intracellular Growth of Francisella tularensis.
    Whiles S, Zhang Q, Chamberlain Z, Singh MK, Steele S, Zheng L, Rosche K, Huang W, Gao H, Zhang Q, Kawula T.
    ACS Infect Dis; 2024 Aug 09; 10(8):2775-2784. PubMed ID: 38876983
    [Abstract] [Full Text] [Related]

  • 33. [Comparative characteristics of biological properties of Francisella tularensis strains isolated in the USSR].
    Pavlovich NV, Mishan'kin BN, Tynkevich NK, Ryzhko IV, Romanova LV, Danilevskaia GI.
    Antibiot Khimioter; 1991 Oct 09; 36(10):23-5. PubMed ID: 1805689
    [Abstract] [Full Text] [Related]

  • 34. Streptomycin and alternative agents for the treatment of tularemia: review of the literature.
    Enderlin G, Morales L, Jacobs RF, Cross JT.
    Clin Infect Dis; 1994 Jul 09; 19(1):42-7. PubMed ID: 7948556
    [Abstract] [Full Text] [Related]

  • 35. In Vitro Antibiotic Susceptibilities of Francisella tularensis Determined by Broth Microdilution following CLSI Methods.
    Heine HS, Miller L, Halasohoris S, Purcell BK.
    Antimicrob Agents Chemother; 2017 Sep 09; 61(9):. PubMed ID: 28674048
    [Abstract] [Full Text] [Related]

  • 36. [Pleiotropic nature of mutation of resistance to 2,3,5-triphenyl- tetrazolium chloride of Francisella tularensis].
    Pavlovich NV, Danilevskaia GI, Khodova VA, Ryzhko IV, Mishan'kin BN.
    Antibiot Khimioter; 1992 Apr 09; 37(4):28-31. PubMed ID: 1417312
    [Abstract] [Full Text] [Related]

  • 37. Tularemia: treatment failures with outpatient use of ceftriaxone.
    Cross JT, Jacobs RF.
    Clin Infect Dis; 1993 Dec 09; 17(6):976-80. PubMed ID: 8110955
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Francisella tularensis as a potential agent of bioterrorism?
    Maurin M.
    Expert Rev Anti Infect Ther; 2015 Feb 09; 13(2):141-4. PubMed ID: 25413334
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.